Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 6 studies | 66% ± 25% | |
endothelial cell | 3 studies | 22% ± 7% | |
astrocyte | 3 studies | 21% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 3 studies | 42% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 33075.69 | 226 / 226 | 87% | 55.87 | 355 / 406 |
brain | 94% | 495.91 | 2473 / 2642 | 30% | 1.16 | 210 / 705 |
ovary | 70% | 77.32 | 126 / 180 | 41% | 1.53 | 177 / 430 |
spleen | 92% | 577.73 | 221 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 73% | 353.76 | 188 / 258 | 7% | 0.86 | 16 / 230 |
esophagus | 29% | 52.11 | 419 / 1445 | 21% | 1.86 | 38 / 183 |
pancreas | 0% | 0.25 | 1 / 328 | 48% | 4.41 | 85 / 178 |
breast | 31% | 38.32 | 144 / 459 | 2% | 0.10 | 23 / 1118 |
uterus | 10% | 12.27 | 17 / 170 | 19% | 0.76 | 87 / 459 |
lung | 1% | 0.59 | 5 / 578 | 17% | 1.09 | 192 / 1155 |
adipose | 17% | 19.75 | 203 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 16% | 0.89 | 7 / 45 |
stomach | 1% | 0.30 | 2 / 359 | 7% | 0.59 | 20 / 286 |
kidney | 6% | 16.31 | 5 / 89 | 1% | 0.04 | 8 / 901 |
intestine | 1% | 0.94 | 10 / 966 | 5% | 0.56 | 28 / 527 |
bladder | 0% | 0 | 0 / 21 | 6% | 0.24 | 30 / 504 |
skin | 1% | 1.45 | 21 / 1809 | 2% | 0.27 | 11 / 472 |
thymus | 2% | 1.47 | 11 / 653 | 1% | 0.08 | 5 / 605 |
eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
peripheral blood | 1% | 2.70 | 11 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 1.02 | 12 / 1335 | 0% | 0 | 0 / 0 |
prostate | 1% | 0.53 | 2 / 245 | 0% | 0 | 0 / 502 |
heart | 1% | 1.07 | 7 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.13 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071422 | Biological process | succinate transmembrane transport |
GO_0015744 | Biological process | succinate transport |
GO_0015746 | Biological process | citrate transport |
GO_0015742 | Biological process | alpha-ketoglutarate transport |
GO_0015741 | Biological process | fumarate transport |
GO_0035674 | Biological process | tricarboxylic acid transmembrane transport |
GO_0035725 | Biological process | sodium ion transmembrane transport |
GO_0055085 | Biological process | transmembrane transport |
GO_0015729 | Biological process | oxaloacetate transport |
GO_0071285 | Biological process | cellular response to lithium ion |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0015141 | Molecular function | succinate transmembrane transporter activity |
GO_0005343 | Molecular function | organic acid:sodium symporter activity |
GO_0015137 | Molecular function | citrate transmembrane transporter activity |
GO_0005515 | Molecular function | protein binding |
GO_0017153 | Molecular function | sodium:dicarboxylate symporter activity |
Gene name | SLC13A5 |
Protein name | Solute carrier family 13 member 5 Na(+)/citrate cotransporter (NaCT) (Sodium-coupled citrate transporter) (Sodium-dependent citrate transporter) (Solute carrier family 13 member 5) |
Synonyms | NACT |
Description | FUNCTION: High-affinity sodium/citrate cotransporter that mediates the entry of citrate into cells, which is a critical participant of biochemical pathways . May function in various metabolic processes in which citrate has a critical role such as energy production (Krebs cycle), fatty acid synthesis, cholesterol synthesis, glycolysis, and gluconeogenesis . Transports citrate into the cell in a Na(+)-dependent manner, recognizing the trivalent form of citrate (physiological pH) rather than the divalent form . Can recognize succinate as a substrate, but its affinity for succinate is several fold lower than for citrate . The stoichiometry is probably 4 Na(+) for each carboxylate, irrespective of whether the translocated substrate is divalent or trivalent, rendering the process electrogenic . Involved in the regulation of citrate levels in the brain (By similarity). . |
Accessions | I3L4X6 ENST00000381074.8 [Q86YT5-4] ENST00000575230.1 ENST00000572352.5 Q86YT5 ENST00000572094.1 ENST00000293800.10 [Q86YT5-3] I3L424 ENST00000570687.1 ENST00000573648.5 [Q86YT5-2] I3L2Y7 I3L4S9 ENST00000433363.7 [Q86YT5-1] |